Deadline to submit for 2019 has passed.
The ISPE Board of Directors has created a special elected category of membership for its outstanding leadership. Fellowship Status is awarded upon election as Fellow by the Board on the recommendation of a committee of peers (the Fellowship & Awards Committee) . Elected members are designated 'ISPE Fellows' (FISPE). Consideration for election to Fellowship is open to those members who are recognized as having leadership roles in pharmacoepidemiology and who are held in high professional standing.
Upon achievement of Fellow Status, Fellows are entitled to:
Fellows must meet or exceed all of the following:
*The review committee will take into account any restriction on publication due to the nature of a candidate's employment when assessing the evidence for scholarship.
**It is essential that you clearly, and in great detail, explain your contributions to the Society. Your response to this section must identify any and all volunteer/leadership positions you've held in the organization and when you served and in what capacity. Please assume that the review committee will not be aware of your contributions to the organization. Examples of service may include committee/council/SIG/chapter Chair/member, abstract reviewer, course faculty, mentor, etc.
The Fellowship and Awards Committee will consider all completed applications received in the ISPE Office for Fellow status to be conferred (deadline for 2019 has passed). The Subcommittee will submit its recommendations to the ISPE Board of Directors for consideration at the Board’s meeting in April. Applicants will be notified of the Board’s decision, following the Board meeting. All applications approved for FISPE status will be inducted at the next Annual Meeting.
Please complete the online application and upload the required documents, or send the following documents to the ISPE office, by the specified deadline (deadline for 2019 has passed):
ISPE –Fellow Nomination
5272 River Road, Suite 500
Bethesda, MD USA 20816
DEADLINE: The deadline for the 2019 year has passed.